Skip to content

Clinical trials

Hypercholesterolemia trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Norway Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20072
20081
20112
20124
20137
20143
20164
20172
20181
20202
20211
20223
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting4
Terminated3
Enrolling by invitation2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
Sanofi6
Merck Sharp & Dohme LLC4
Kowa Research Europe3
LIB Therapeutics LLC3
Regeneron Pharmaceuticals3
University of Oslo2
AstraZeneca1
Daiichi Sankyo1
Kastle Therapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia42
Dyslipidemias8
Hyperlipidemias5
Hyperlipoproteinemia Type II5
Arteriosclerosis1
Atherosclerosis1
Body Weight Changes1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Genetic Diseases, Inborn1

Trials

Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.